MiNDERA Corporation Company
MiNDERA Dx conducts research and development on non-invasive molecular testing for skin cancer and other skin diseases. The company is currently focused on a technology solution to extract skin biomarkers in a non-invasive manner.
MiNDERA Dx was founded in 2013 and is based in San Francisco, United States.
Funding Status:
undisclosed
Industry:
Precision Medicine
Number Of Exists:
N/A
Technology:
Personalized Diagnostics
Founded Date:
2013
Investor Type:
N/A
Headquarters:
South San Francisco
Employee Number:
11-50
Investment Stage:
N/A